January 2013 
Volume 43  Number 1
Pages 9 - 9
  PDF Version Available!

In a double-blind, double-placebo-controlled trial, researchers compared oral anticholinergic therapy with onabotulinumtoxinA injections to treat women with idiopathic urgency urinary incontinence. The participants had experienced five or more episodes of urgency urinary incontinence per 3-day period, as documented in patient diaries. The primary outcome at 6 months was a reduction in the daily average of urgency urinary incontinence incidents. Secondary outcomes included resolution of urgency urinary incontinence, quality of life, catheter use, and adverse events.In the oral anticholinergic group, the average reduction in incidents of urgency urinary incontinence from baseline (5.0 per day) was 3.4, compared with 3.3 in the onabotulinumtoxinA injection group. Resolution of urgency urinary incontinence was 13% and 27%, respectively.Researchers found that oral anticholinergic medications and onabotulinumtoxinA injections were associated with "similar reductions" in daily urgency urinary

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events